Brief: Innovent Biologics Logs H1 Adjusted Net Income RMB 1,213.2 Mln
27/08/2025 10:35
Aug 27 (Reuters) - Innovent Biologics Inc 1801.HK: H1 ADJUSTED NET INCOME RMB 1,213.2 MILLION H1 NET INCOME RMB 834.3 MILLION HY REVENUE RMB5.95 BLN Further company coverage: 1801.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Innovent Biologics
See all newsChina emerges as obesity drug lab for Big Pharma
Eli Lilly becomes first drugmaker to have a GLP-1 weight-loss pill approved in China (updated)
China emerges as obesity drug lab for Big Pharma
Pfizer raises 2026 forecasts as Eliquis, cancer drugs drive third-quarter results (updated)
Refile: Pfizer raises 2026 forecast on strong demand for blood thinner Eliquis